| abstract |
The invention concerns the use of a 2β,16β-diamino-3α,17-dihydroxy androstane derivative of the formulan n in which R₁, R₂, R₃, and R₄ are independently selected from hydrogen, (C₁₋₆) alkyl, (C₇₋₁₂) aralkyl, (C₂₋₆) acyl, and (C₃₋₇) cycloalkyl which is optionally substituted with (C₁₋₆) alkyl, or R₁ and R₂, and/or R₃ and R₄ together with the nitrogen atom to which they are bonded represent a 5-, 6-, or 7-membered ring which is optionally substituted with (C₁₋₆) alkyl, and the twitched line represents an α or β bond, or pharmaceutically acceptable salts thereof, for the manufacture of a medicament for treating arrhythmic disorders. |